247 related articles for article (PubMed ID: 19627527)
1. Enamel matrix proteins; old molecules for new applications.
Lyngstadaas SP; Wohlfahrt JC; Brookes SJ; Paine ML; Snead ML; Reseland JE
Orthod Craniofac Res; 2009 Aug; 12(3):243-53. PubMed ID: 19627527
[TBL] [Abstract][Full Text] [Related]
2. Human periodontal fibroblast response to enamel matrix derivative, amelogenin, and platelet-derived growth factor-BB.
Chong CH; Carnes DL; Moritz AJ; Oates T; Ryu OH; Simmer J; Cochran DL
J Periodontol; 2006 Jul; 77(7):1242-52. PubMed ID: 16805689
[TBL] [Abstract][Full Text] [Related]
3. Effects and distribution of the enamel matrix derivative Emdogain in the periodontal tissues of rat molars transplanted to the abdominal wall.
Hamamoto Y; Kawasaki N; Jarnbring F; Hammarström L
Dent Traumatol; 2002 Feb; 18(1):12-23. PubMed ID: 11841461
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of matrix molecules associated with wound healing following treatment with an enamel matrix protein derivative in humans.
Sculean A; Junker R; Donos N; Windisch P; Brecx M; Dünker N
Clin Oral Investig; 2003 Sep; 7(3):167-74. PubMed ID: 12827455
[TBL] [Abstract][Full Text] [Related]
5. Biological mediators for periodontal regeneration.
Cochran DL; Wozney JM
Periodontol 2000; 1999 Feb; 19():40-58. PubMed ID: 10321215
[TBL] [Abstract][Full Text] [Related]
6. Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.
Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD003875. PubMed ID: 19821315
[TBL] [Abstract][Full Text] [Related]
7. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
[TBL] [Abstract][Full Text] [Related]
8. Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN).
Okuda K; Miyazaki A; Momose M; Murata M; Nomura T; Kubota T; Wolff LF; Yoshie H
J Periodontal Res; 2001 Oct; 36(5):309-16. PubMed ID: 11585118
[TBL] [Abstract][Full Text] [Related]
9. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins.
Hammarström L; Heijl L; Gestrelius S
J Clin Periodontol; 1997 Sep; 24(9 Pt 2):669-77. PubMed ID: 9310871
[TBL] [Abstract][Full Text] [Related]
10. [The use of Emdogain in periodontal and osseous regeneration].
Sculean A; Rathe F; Junker R; Becker J; Schwarz F; Arweiler N
Schweiz Monatsschr Zahnmed; 2007; 117(6):598-606. PubMed ID: 17691421
[TBL] [Abstract][Full Text] [Related]
11. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting.
Cochran DL; Jones A; Heijl L; Mellonig JT; Schoolfield J; King GN
J Periodontol; 2003 Sep; 74(9):1269-81. PubMed ID: 14584859
[TBL] [Abstract][Full Text] [Related]
12. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
Esposito M; Grusovin MG; Coulthard P; Worthington HV
Cochrane Database Syst Rev; 2005 Oct; (4):CD003875. PubMed ID: 16235343
[TBL] [Abstract][Full Text] [Related]
13. Favorable periodontal healing of 1-wall infrabony defects after application of calcium phosphate cement wall alone or in combination with enamel matrix derivative: a pilot study with canine mandibles.
Shirakata Y; Yoshimoto T; Goto H; Yonamine Y; Kadomatsu H; Miyamoto M; Nakamura T; Hayashi C; Izumi Y
J Periodontol; 2007 May; 78(5):889-98. PubMed ID: 17470023
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
Gurinsky BS; Mills MP; Mellonig JT
J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a porcine amelogenin preparation, EMDOGAIN, a biological treatment for periodontal disease.
Maycock J; Wood SR; Brookes SJ; Shore RC; Robinson C; Kirkham J
Connect Tissue Res; 2002; 43(2-3):472-6. PubMed ID: 12489200
[TBL] [Abstract][Full Text] [Related]
16. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
Esposito M; Coulthard P; Worthington HV
Cochrane Database Syst Rev; 2003; (2):CD003875. PubMed ID: 12804493
[TBL] [Abstract][Full Text] [Related]
17. Healing of periodontal defects treated with enamel matrix proteins and root surface conditioning--an experimental study in dogs.
Sakallioğlu U; Açikgöz G; Ayas B; Kirtiloğlu T; Sakallioğlu E
Biomaterials; 2004 May; 25(10):1831-40. PubMed ID: 14738847
[TBL] [Abstract][Full Text] [Related]
18. Common epitopes of mammalian amelogenins at the C-terminus and possible functional roles of the corresponding domain in enamel mineralization.
Aoba T; Shimoda S; Shimokawa H; Inage T
Calcif Tissue Int; 1992 Jul; 51(1):85-91. PubMed ID: 1382821
[TBL] [Abstract][Full Text] [Related]
19. Effect of enamel matrix derivative on periodontal wound healing and regeneration in an osteoporotic model.
Miron RJ; Wei L; Yang S; Caluseru OM; Sculean A; Zhang Y
J Periodontol; 2014 Nov; 85(11):1603-11. PubMed ID: 24857323
[TBL] [Abstract][Full Text] [Related]
20. Presence of an enamel matrix protein derivative on human teeth following periodontal surgery.
Sculean A; Windisch P; Keglevich T; Fabi B; Lundgren E; Lyngstadaas PS
Clin Oral Investig; 2002 Sep; 6(3):183-7. PubMed ID: 12271353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
